Featured Image
Why is it important?
The rapid production capacity and the synthetic origin of the vaccine make this platform particularly exploitable in case of an influenza pandemic.
Perspectives
If the SAM vaccine platform proves safe, well tolerated, and effective in humans, the fully synthetic SAM vaccine technology could provide a rapid response platform to control pandemic influenza.
Dr Sylvie Bertholet
GSK Vaccines US
Read the Original
This page is a summary of: Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin, Journal of Virology, October 2015, ASM Journals,
DOI: 10.1128/jvi.01786-15.
You can read the full text:
Contributors
The following have contributed to this page
